Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Bioprocess and bioscience company reports second quarter revenues
August 15th, 2005
Millipore Corporation (MIL) announced that its second quarter revenues were $245 million, up 9% from the same period of 2004. In constant currency, revenue growth was 6%. For the first half of the year, revenues were $495 million, up 11%. In constant currency, growth was 8% for the first half of the year. Second quarter earnings were $0.47 per share, compared with $0.57 per share last year. Included in the results for the quarter were pretax expenses of $3.8 million related to executive transition agreements, $3.2 million of division reorganization costs and manufacturing consolidation costs of $2.6 million. Excluding these items,...
Source: Pharma Business Week (2005-08-15)
|
